- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03408704
Antimicrobial Stewardship Program (ASP) in Patients With a Sore Throat (ASP-Throat)
The Effectiveness of an Antimicrobial Stewardship Program (ASP) in Primary Health Care in the Management of Patients With a Sore Throat
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Vastra Gotaland
-
Borås, Vastra Gotaland, Sweden, 50338
- Vastra Gotaland Region
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Being a primary health care center in the Vastra Gotaland region, Sweden accepting participation
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ASP-arm
This group of primary health care centers get the internal education (ASP).
|
It consists of one educational session where doctors and staff at the center discuss current guidelines around management of patients attending for a sore throat. At the education the following is discussed:
|
No Intervention: Control-arm
No intervention at all.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The effect of an ASP on the change in proportion of positive RADT among patients prescribed AB - 6m
Time Frame: Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 6 months
|
The effect of an antibiotic stewardship program (ASP) on the proportion of patients prescribed antibiotics (J01 excluding methenamine) for a sore throat where a rapid antigen detection test (RADT) to detect Group A Streptococcus (GAS) is taken and is positive. Change from a 6 month period before initiation of the intervention (baseline) is compared with a time period of 6 months prior to the follow up date. The change from baseline to follow-up in all primary health care centres (PHCC) in the intervention group is compared to the corresponding change in PHCC in the control group (ASP group versus control group) using linear regression where adjustment will also be made for: the number of enlisted patients at baseline, location in cities versus small villages, Adjusted Clinical Group (ACG), Care-need index (CNI) and type of PHCC (private/public). |
Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 6 months
|
The effect of an ASP on the change in proportion of positive RADT among patients prescribed AB - 12m
Time Frame: Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 12 months
|
The effect of an antibiotic stewardship program (ASP) on the proportion of patients prescribed antibiotics (J01 excluding methenamine) for a sore throat where a rapid antigen detection test (RADT) to detect Group A Streptococcus (GAS) is taken and is positive. Change from a 6 month period before initiation of the intervention (baseline) is compared with a time period of 6 months prior to the follow up date. The change from baseline to follow-up in all primary health care centres (PHCC) in the intervention group is compared to the corresponding change in PHCC in the control group (ASP group versus control group) using linear regression where adjustment will also be made for: the number of enlisted patients at baseline, location in cities versus small villages, Adjusted Clinical Group (ACG), Care-need index (CNI) and type of PHCC (private/public). |
Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 12 months
|
The effect of an ASP on the change in proportion of positive RADT among patients prescribed AB - 18m
Time Frame: Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 18 months
|
The effect of an antibiotic stewardship program (ASP) on the proportion of patients prescribed antibiotics (J01 excluding methenamine) for a sore throat where a rapid antigen detection test (RADT) to detect Group A Streptococcus (GAS) is taken and is positive. Change from a 6 month period before initiation of the intervention (baseline) is compared with a time period of 6 months prior to the follow up date. The change from baseline to follow-up in all primary health care centres (PHCC) in the intervention group is compared to the corresponding change in PHCC in the control group (ASP group versus control group) using linear regression where adjustment will also be made for: the number of enlisted patients at baseline, location in cities versus small villages, Adjusted Clinical Group (ACG), Care-need index (CNI) and type of PHCC (private/public). |
Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The effect of an ASP on the change in proportion of negative RADT given AB - 6m
Time Frame: Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 6 months
|
The effect of an antibiotic stewardship program (ASP) on the proportion of patients prescribed antibiotics (J01 excluding methenamine) for a sore throat where a rapid antigen detection test (RADT) to detect Group A Streptococcus (GAS) is taken and is negative being. Change from a 6 month period before initiation of the intervention (baseline) is compared with a time period of 6 months prior to the follow up date. The change from baseline to follow-up in all primary health care centres (PHCC) in the intervention group is compared to the corresponding change in PHCC in the control group (ASP group versus control group) using linear regression where adjustment will also be made for: the number of enlisted patients at baseline, location in cities versus small villages, Adjusted Clinical Group (ACG), Care-need index (CNI) and type of PHCC (private/public). |
Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 6 months
|
The effect of an ASP on the change in proportion of negative RADT given AB - 12m
Time Frame: Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 12 months
|
The effect of an antibiotic stewardship program (ASP) on the proportion of patients prescribed antibiotics (J01 excluding methenamine) for a sore throat where a rapid antigen detection test (RADT) to detect Group A Streptococcus (GAS) is taken and is negative being. Change from a 6 month period before initiation of the intervention (baseline) is compared with a time period of 6 months prior to the follow up date. The change from baseline to follow-up in all primary health care centres (PHCC) in the intervention group is compared to the corresponding change in PHCC in the control group (ASP group versus control group) using linear regression where adjustment will also be made for: the number of enlisted patients at baseline, location in cities versus small villages, Adjusted Clinical Group (ACG), Care-need index (CNI) and type of PHCC (private/public). |
Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 12 months
|
The effect of an ASP on the change in proportion of negative RADT given AB - 18m
Time Frame: Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 18 months
|
The effect of an antibiotic stewardship program (ASP) on the proportion of patients prescribed antibiotics (J01 excluding methenamine) for a sore throat where a rapid antigen detection test (RADT) to detect Group A Streptococcus (GAS) is taken and is negative being. Change from a 6 month period before initiation of the intervention (baseline) is compared with a time period of 6 months prior to the follow up date. The change from baseline to follow-up in all primary health care centres (PHCC) in the intervention group is compared to the corresponding change in PHCC in the control group (ASP group versus control group) using linear regression where adjustment will also be made for: the number of enlisted patients at baseline, location in cities versus small villages, Adjusted Clinical Group (ACG), Care-need index (CNI) and type of PHCC (private/public). |
Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 18 months
|
The effect of an ASP on the change in proportion of recommended AB prescribed - 6m
Time Frame: Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 6 months
|
The effect of an antibiotic stewardship program (ASP) on the proportion of patients prescribed PcV compared to all patients prescribed any antibiotics (J01 excluding methenamine) for a sore throat. Change from a 6 month period before initiation of the intervention (baseline) is compared with a time period of 6 months prior to the follow up date. The change from baseline to follow-up in all primary health care centres (PHCC) in the intervention group is compared to the corresponding change in PHCC in the control group (ASP group versus control group) using linear regression where adjustment will also be made for: the number of enlisted patients at baseline, location in cities versus small villages, Adjusted Clinical Group (ACG), Care-need index (CNI) and type of PHCC (private/public). |
Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 6 months
|
The effect of an ASP on the change in proportion of recommended AB prescribed - 12m
Time Frame: Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 12 months
|
The effect of an antibiotic stewardship program (ASP) on the proportion of patients prescribed PcV compared to all patients prescribed any antibiotics (J01 excluding methenamine) for a sore throat. Change from a 6 month period before initiation of the intervention (baseline) is compared with a time period of 6 months prior to the follow up date. The change from baseline to follow-up in all primary health care centres (PHCC) in the intervention group is compared to the corresponding change in PHCC in the control group (ASP group versus control group) using linear regression where adjustment will also be made for: the number of enlisted patients at baseline, location in cities versus small villages, Adjusted Clinical Group (ACG), Care-need index (CNI) and type of PHCC (private/public). |
Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 12 months
|
The effect of an ASP on the change in proportion of recommended AB prescribed - 18m
Time Frame: Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 18 months
|
The effect of an antibiotic stewardship program (ASP) on the proportion of patients prescribed PcV compared to all patients prescribed any antibiotics (J01 excluding methenamine) for a sore throat. Change from a 6 month period before initiation of the intervention (baseline) is compared with a time period of 6 months prior to the follow up date. The change from baseline to follow-up in all primary health care centres (PHCC) in the intervention group is compared to the corresponding change in PHCC in the control group (ASP group versus control group) using linear regression where adjustment will also be made for: the number of enlisted patients at baseline, location in cities versus small villages, Adjusted Clinical Group (ACG), Care-need index (CNI) and type of PHCC (private/public). |
Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 18 months
|
The effect of an ASP on the change in proportion of patients where CRP is requested - 6m
Time Frame: Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 6 months
|
The effect of an antibiotic stewardship program (ASP) on the proportion of patients diagnosed with pharyngotonsillitis where the lab test C-reactive protein (CRP) is requested. Change from a 6 month period before initiation of the intervention (baseline) is compared with a time period of 6 months prior to the follow up date. The change from baseline to follow-up in all primary health care centres (PHCC) in the intervention group is compared to the corresponding change in PHCC in the control group (ASP group versus control group) using linear regression where adjustment will also be made for: the number of enlisted patients at baseline, location in cities versus small villages, Adjusted Clinical Group (ACG), Care-need index (CNI) and type of PHCC (private/public). |
Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 6 months
|
The effect of an ASP on the change in proportion of patients where CRP is requested - 12m
Time Frame: Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 12 months
|
The effect of an antibiotic stewardship program (ASP) on the proportion of patients diagnosed with pharyngotonsillitis where the lab test C-reactive protein (CRP) is requested. Change from a 6 month period before initiation of the intervention (baseline) is compared with a time period of 6 months prior to the follow up date. The change from baseline to follow-up in all primary health care centres (PHCC) in the intervention group is compared to the corresponding change in PHCC in the control group (ASP group versus control group) using linear regression where adjustment will also be made for: the number of enlisted patients at baseline, location in cities versus small villages, Adjusted Clinical Group (ACG), Care-need index (CNI) and type of PHCC (private/public). |
Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 12 months
|
The effect of an ASP on the change in proportion of patients where CRP is requested - 18m
Time Frame: Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 18 months
|
The effect of an antibiotic stewardship program (ASP) on the proportion of patients diagnosed with pharyngotonsillitis where the lab test C-reactive protein (CRP) is requested. Change from a 6 month period before initiation of the intervention (baseline) is compared with a time period of 6 months prior to the follow up date. The change from baseline to follow-up in all primary health care centres (PHCC) in the intervention group is compared to the corresponding change in PHCC in the control group (ASP group versus control group) using linear regression where adjustment will also be made for: the number of enlisted patients at baseline, location in cities versus small villages, Adjusted Clinical Group (ACG), Care-need index (CNI) and type of PHCC (private/public). |
Pre intervention 6 Months period compared to the 6 months period prior to follow-up at 18 months
|
Proportion of patients given AB for a sore throat with no throat swab taken
Time Frame: Pre intervention 6 Months period
|
The proportion of patients given a diagnosis of pharyngotonsillitis and prescribed AB (J01 excluding methenamine) where a throat swab is not taken. Descriptive statistics is presented and a group comparison is not made. |
Pre intervention 6 Months period
|
Proportion of patients with pharyngotonsillitis where a throat swab is taken and sent for a culture
Time Frame: Pre intervention 6 Months period
|
The proportion of patients given a diagnosis of pharyngotonsillitis and where a throat swab is taken and send to a microbiologic laboratory for a throat culture. Descriptive statistics is presented and a group comparison is not made. |
Pre intervention 6 Months period
|
Proportion of patients with pharyngotonsillitis where a test for mononucleosis is taken
Time Frame: Pre intervention 6 Months period
|
The proportion of patients given a diagnosis of pharyngotonsillitis and where a test for mononucleosis is taken. Descriptive statistics is presented and a group comparison is not made. |
Pre intervention 6 Months period
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Pär-Daniel Sundvall, MD PhD, Vastra Gotaland region, Sweden
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- U1111-1207-9573
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tonsillitis
-
Turku University HospitalRecruitingTonsillitis | Tonsillitis Chronic | Tonsil Disease | Tonsillitis AcuteFinland
-
Aarhus University HospitalSkodstrup Medical Clinic, DenmarkUnknownStreptococcal Acute TonsillitisDenmark
-
Oulu University HospitalCompletedTonsillitis Chronic | Tonsillitis RecurrentFinland
-
Assiut UniversityUnknownAcute Follicular Tonsillitis
-
China Academy of Chinese Medical SciencesBeijing Chao Yang Hospital; The First Affiliated Hospital of Henan University... and other collaboratorsUnknownAcute Tonsillitis
-
Combined Military Hospital, PakistanCompleted
-
Bait Balev HospitalUnknownTonsillitis | Tonsillitis StreptococcalIsrael
-
Pamukkale UniversityCompletedOSAS | Recurrent TonsillitisTurkey
-
Pamukkale UniversityRecruitingSleep Apnea | Tonsillitis RecurrentTurkey
-
HaEmek Medical Center, IsraelCompletedViral Pharyngitis | Viral TonsillitisIsrael
Clinical Trials on ASP
-
University of ChicagoAsphelia PharmaceuticalsCompletedAllergic RhinitisUnited States
-
Rakuten Medical, Inc.National Cancer Institute (NCI); Shimadzu CorporationRecruitingHead and Neck Cancer | Squamous Cell Carcinoma of Head and NeckUnited States
-
ASP HealthMayo ClinicNot yet recruitingLung Diseases | Lung Cancer
-
University of TorontoSinai Health SystemUnknownSore Throat | Acute Rhinosinusitis | Acute Bronchitis | Acute CystitisCanada
-
The University of Hong KongUnknown
-
Iowa State UniversityCompletedIron-deficiency | Bioavailability | Anemia, Iron Deficiency | Absorption; Iron | Serum IronUnited States
-
Oslo Metropolitan UniversityNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedQuality of Life | Physical Activity | Children | Motor Activity | Competence | Autonomy | Activity Play | After-School Program
-
The Hong Kong Polytechnic UniversityTuen Mun HospitalRecruitingCoronary Heart DiseaseHong Kong
-
Landstuhl Regional Medical CenterCompleted
-
Rakuten Medical, Inc.Active, not recruiting